Toluene diisocyanate (mixed isomers)

Commercial toluene diisocyanate (TDI) is produced industrially by phosgenation of toluenediamine and is sold primarily as a mixture of approximately 80% 2,4-TDI and 20% 2,6-TDI isomers. [1] This 80:20 mixture reflects the relative proportions naturally produced by the manufacturing process (nitration of toluene followed by reduction and phosgenation) and has been the standard commercial form since polyurethane technology was commercialized by Bayer in Germany and DuPont in the United States in the late 1940s and 1950s. TDI is the largest-volume diisocyanate globally, with annual production measured in millions of tons, primarily consumed in the production of flexible polyurethane foams for furniture, bedding, and automotive seating. The 80:20 isomer ratio gives this mixture its handling properties — the 2,4 isomer has two differently reactive NCO groups due to steric and electronic differences, enabling controlled two-stage reactions in foam manufacturing. [2] Health concerns emerged in the 1950s when foam factory workers began reporting asthma outbreaks. By the 1970s, TDI had become a paradigm case in occupational respiratory medicine, establishing the concept of isocyanate-induced occupational asthma — a condition distinct from common allergic asthma in its mechanism, prognosis, and the absolute requirement for exposure elimination as treatment. The 80:20 mixture CAS (26471-62-5) represents the combined industrial product and is regulated identically to its component isomers under OSHA and EPA standards. [3]

Occupational exposure occurs primarily in polyurethane foam manufacturing, mattress and furniture production, auto upholstery, spray foam insulation installation, and polyurethane coating and adhesive applications. Vapor generation is highest during reactive foam-forming operations and spray application. Heated or flame-cut polyurethane foam can also generate TDI vapors. Consumer off-gassing from new foam products causes brief, low-level exposure. Firefighters at polyurethane fires can receive significant acute exposures to TDI and its combustion byproducts.

The dominant hazard of TDI is respiratory sensitization causing occupational asthma — affecting an estimated 5–15% of occupationally exposed workers who develop sensitization. [2] Once sensitized, asthma attacks can be triggered by even trace-level TDI exposures, and the condition often becomes a permanent disability requiring career change. Skin sensitization and dermatitis also occur. NTP animal studies found evidence of respiratory tract tumors at high inhalation exposures, supporting a potential carcinogenicity classification. The compound is listed as a HAP under the Clean Air Act and is among the substances prioritized for emission reduction at foam manufacturing facilities.

Workers in the flexible polyurethane foam industry are the primary at-risk population, particularly those in pouring rooms, foam-cutting operations, and spray booths. Spray foam insulation contractors — a rapidly growing workforce — face high exposures from open-spray operations. Auto body refinishers applying TDI-based clearcoats are another significant group. Emergency responders at foam fires face acute high-dose exposure risks.

1. All TDI handling should occur with continuous local exhaust ventilation; spray operations require supplied-air (not air-purifying) respirators since air-purifying respirators do not reliably protect against isocyanate sensitization. 2. Conduct biological monitoring (urinary TDA) and regular spirometry for production workers. 3. Investigate any new respiratory symptoms in exposed workers with specific IgE testing and spirometry immediately — do not wait for symptoms to become severe. 4. Consider substituting water-blown, aliphatic-isocyanate, or bio-based polyurethane formulations where technically feasible. 5. Contractors installing spray polyurethane foam should follow EPA's 6H rule (occupants excluded for 6 hours minimum post-application).